| Earnings (Loss) Per Share |
5. Earnings (Loss) Per Share
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average shares of common stock outstanding. For purposes of calculating diluted earnings (loss) per share, the denominator includes both the weighted average shares of common stock outstanding and dilutive common stock equivalents. Dilutive common stock equivalents consist of stock options, restricted stock unit awards and warrants calculated under the treasury stock method.
The calculations of earnings (loss) per share are as follows:
|
|
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
|
(In thousands, except per share amounts) |
|
2016 |
|
|
2015 |
|
|
2016 |
|
|
2015 |
|
|
Basic Loss per Common Share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
157 |
|
|
$ |
(5,133 |
) |
|
$ |
148 |
|
|
$ |
(18,433 |
) |
|
Less: Net income attributable to non-controlling interest |
|
$ |
(151 |
) |
|
$ |
(111 |
) |
|
$ |
(142 |
) |
|
$ |
(120 |
) |
|
Less: Accretion of redemption preference on redeemable
convertible non-controlling interest |
|
$ |
(10,191 |
) |
|
$ |
0 |
|
|
$ |
(18,344 |
) |
|
$ |
0 |
|
|
Net loss attributable to Allscripts Healthcare Solutions, Inc.
stockholders |
|
$ |
(10,185 |
) |
|
$ |
(5,244 |
) |
|
$ |
(18,338 |
) |
|
$ |
(18,553 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
186,226 |
|
|
|
188,944 |
|
|
|
187,190 |
|
|
|
183,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic Loss per Common Share |
|
$ |
(0.06 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.10 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Loss per Common Share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
157 |
|
|
$ |
(5,133 |
) |
|
$ |
148 |
|
|
$ |
(18,433 |
) |
|
Less: Net income attributable to non-controlling interest |
|
$ |
(151 |
) |
|
$ |
(111 |
) |
|
$ |
(142 |
) |
|
$ |
(120 |
) |
|
Less: Accretion of redemption preference on redeemable
convertible non-controlling interest |
|
$ |
(10,191 |
) |
|
$ |
0 |
|
|
$ |
(18,344 |
) |
|
$ |
0 |
|
|
Net loss attributable to Allscripts Healthcare Solutions, Inc.
stockholders |
|
$ |
(10,185 |
) |
|
$ |
(5,244 |
) |
|
$ |
(18,338 |
) |
|
$ |
(18,553 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
186,226 |
|
|
|
188,944 |
|
|
|
187,190 |
|
|
|
183,725 |
|
|
Dilutive effect of stock options, restricted stock unit awards
and warrants |
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
Weighted-average common shares outstanding assuming
dilution |
|
|
186,226 |
|
|
|
188,944 |
|
|
|
187,190 |
|
|
|
183,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Loss per Common Share |
|
$ |
(0.06 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.10 |
) |
As a result of the net loss attributable to Allscripts Healthcare Solutions, Inc. stockholders for the three and nine months ended September 30, 2016 and 2015, we used basic weighted-average common shares outstanding in the calculation of diluted loss per share for that period, since the inclusion of any stock equivalents would be anti-dilutive.
The following stock options, restricted stock unit awards and warrants are not included in the computation of diluted earnings (loss) per share as the effect of including such stock options, restricted stock unit awards and warrants in the computation would be anti-dilutive:
|
|
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
|
(In thousands) |
|
2016 |
|
|
2015 |
|
|
2016 |
|
|
2015 |
|
|
Shares subject to anti-dilutive stock options, restricted stock
unit awards and warrants excluded from calculation |
|
|
27,580 |
|
|
|
23,562 |
|
|
|
26,219 |
|
|
|
25,359 |
|
|